Skip to content

The effect of yarrow flowers cream on healing of episiotomy in primiparous women: a randomized clinical trial

The effect of achillea flowers cream compared to routin care (betadin) on healing of episiotomy in primiparous women: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017053134261N1
Enrollment
56
Registered
2017-08-10
Start date
2017-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing. Disruption of perineal obstetric wound

Interventions

Intervention 1: In the intervention group, patients will treat with yarrow cream
thus the site of sutures will cover with the cream (1.5 percent) twice a day (for ten Days). Intervention 2: The control group will be placed under routine care (iodine solution). The diluted solution
Treatment - Drugs
In the intervention group, patients will treat with yarrow cream
thus the site of sutures will cover with the cream (1.5 percent) twice a day (for ten Days).
The control group will be placed under routine care (iodine solution). The diluted solution will be made up and used twice a day (for ten days) by patients.

Sponsors

Research Deputy of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria:primary par women; natural delivery with medio lateral episiotomy; living with her husband; absence of diseases disturbing wound healing (such as chronic systemic diseases, heart, kidney, liver, respiratory, coagulation, tissue, diabetes, anemia, cancer and mental illness); absence of using drugs affecting wound healing (such as glucocorticoids, anticoagulants, immunosuppressant, antibiotics and chemotherapy drugs); single fetus with anterior cephalic presentation; absence of symptomatic infection of the vagina and vulva (infectious discharge, itching and burning sensation); no obvious abnormalities in infants (hydrocephalus, ascites, a huge mass in the body); no Rectocele and severe Cystocels (grade 2 and above) or vaginal mass; no history of obstetric problems (placenta previa, placental abruption, multiple pregnancy, polyhydramnios, oligohydramnios, conflict RH, rupture of the membranes more than 12 hours); BMI in limited 19/8-30 kilograms per square meter; absence of reconstructive surgery on the vagina and perineum. Exclusion criteria: Disordering in the progress of labor (fast delivery and prolonged labor); lasted the second stage of labor more than 2 hours; extending the incision and converting into the 3rd and 4th degree tears or extending tears other than episiotomy; abnormal vaginal bleeding (abnormal vaginal bleeding that requires further evaluation by valve); shoulder dystocia that led to the use of non-Mac Robert maneuvers; Placental withdrawal by hand.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Wound healing. Timepoint: 1th, 7th and 10th day after intervention. Method of measurement: REEDA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMs KArdan-moghaddam

Tehran University of Medical Sciences

azamrahmani7@gmail.com+98 21 8163 3605

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026